SLC5A1 and myocardial ischemia: The non-selective SGLT1/2 inhibitor phlorizin exacerbated LV dysfunction following ex vivo myocardial ischemia–reperfusion injury in mice via inhibiting glucose uptake, suggesting that SGLT1 might play a compensatory protective role in acute ischemia [19, 21].